Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
2,583
2,583
2,566
2,671
2,802
2,922
Revenue Growth (YoY)
1%
1%
-4%
-5%
-4%
15%
Cost of Revenue
1,239
1,239
1,187
1,240
1,233
1,259
Gross Profit
1,343
1,343
1,378
1,430
1,568
1,663
Selling, General & Admin
819
819
814
824
824
851
Research & Development
257
257
266
240
256
247
Operating Expenses
1,077
1,077
1,080
1,065
1,081
1,098
Other Non Operating Income (Expenses)
0
0
1
4
-2
0
Pretax Income
995
995
-2,342
-850
-4,704
5,449
Income Tax Expense
235
235
-498
-212
-1,076
1,194
Net Income
759
759
-1,844
-637
-3,627
4,254
Net Income Growth
-141%
-141%
189%
-82%
-185%
12%
Shares Outstanding (Diluted)
27.01
27.28
28.21
29.2
29.8
30.2
Shares Change (YoY)
-4%
-3%
-3%
-2%
-1%
0%
EPS (Diluted)
28.12
27.85
-65.36
-21.81
-121.72
140.87
EPS Growth
-143%
-143%
200%
-82%
-186%
12%
Free Cash Flow
374
374
266
218
81
535
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
51.99%
51.99%
53.7%
53.53%
55.96%
56.91%
Operating Margin
10.29%
10.29%
11.61%
13.66%
17.34%
19.3%
Profit Margin
29.38%
29.38%
-71.86%
-23.84%
-129.44%
145.58%
Free Cash Flow Margin
14.47%
14.47%
10.36%
8.16%
2.89%
18.3%
EBITDA
--
--
301
371
--
--
EBITDA Margin
--
--
11.73%
13.88%
--
--
D&A For EBITDA
--
--
3
6
--
--
EBIT
266
266
298
365
486
564
EBIT Margin
10.29%
10.29%
11.61%
13.66%
17.34%
19.3%
Effective Tax Rate
23.61%
23.61%
21.26%
24.94%
22.87%
21.91%
Follow-Up Questions
What are Bio Rad Laboratories Inc's key financial statements?
According to the latest financial statement (Form-10K), Bio Rad Laboratories Inc has a total asset of $10,576, Net profit of $759
What are the key financial ratios for BIO?
Bio Rad Laboratories Inc's Current ratio is 3.38, has a Net margin is 29.38, sales per share of $94.68.
How is Bio Rad Laboratories Inc's revenue broken down by segment or geography?
Bio Rad Laboratories Inc largest revenue segment is Life Science, at a revenue of 1,021,100,000 in the most earnings release.For geography, United States is the primary market for Bio Rad Laboratories Inc, at a revenue of 1,022,700,000.
Is Bio Rad Laboratories Inc profitable?
yes, according to the latest financial statements, Bio Rad Laboratories Inc has a net profit of $759
Does Bio Rad Laboratories Inc have any liabilities?
yes, Bio Rad Laboratories Inc has liability of 3,122
How many outstanding shares for Bio Rad Laboratories Inc?
Bio Rad Laboratories Inc has a total outstanding shares of 26.99